Sunitinib
Modify Date: 2024-01-03 11:45:22
Sunitinib structure
|
Common Name | Sunitinib | ||
|---|---|---|---|---|
| CAS Number | 342641-94-5 | Molecular Weight | 398.474 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 572.1±50.0 °C at 760 mmHg | |
| Molecular Formula | C22H27FN4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 299.8±30.1 °C | |
| Name | N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 572.1±50.0 °C at 760 mmHg |
| Molecular Formula | C22H27FN4O2 |
| Molecular Weight | 398.474 |
| Flash Point | 299.8±30.1 °C |
| Exact Mass | 398.211792 |
| PSA | 77.23000 |
| LogP | 3.15 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.611 |
| HS Code | 2933990090 |
|---|
|
~%
Sunitinib CAS#:342641-94-5 |
| Literature: WO2010/49449 A2, ; Page/Page column 16; 17 ; |
|
~45%
Sunitinib CAS#:342641-94-5 |
| Literature: RATIOPHARM GMBH; CHRIST, Jochen; STRIEGEL, Hans-Guenter Patent: WO2010/136458 A1, 2010 ; Location in patent: Page/Page column 27; 28 ; |
![N-[2-(DiethylaMino)ethyl]-2,4-diMethyl-1H-pyrrole-3-CarboxaMide structure](https://image.chemsrc.com/caspic/431/590424-05-8.png)
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| sunitinibum |
| 1-[carbaMoyl(diethylaMino)Methyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)Methyl]-2,4-diMethyl-1H-pyrrole-3-carboxylic acid |
| bis(N-[2-(diethylaMino)ethyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)Methyl]-2,4-diMethyl-1H-pyrrole-3-carbox |
| 1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl- |
| SU11248 |
| 5-(5-fluoro-2-oxo-1,2-dihydroindole-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide |
| 1H-PYRROLE-3-CARBOXAMIDE,N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-(9CI) |
| Sunitinib |
| N-[2-(diethylamino)ethyl]-5-[-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylicacid(2-diethylamino-ethyl)-am |
| 1H-PYRROLE-3-CARBOXAMIDE,N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL |
| 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylicacid(2-diethylamino-ethyl)-amide |
| N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |